Current and historical daily PE Ratio for QTTB (
Q32 Bio Inc
) from 2024 to Jun 04 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Q32 Bio stock (QTTB) PE ratio as of Jun 04 2024 is 0.
More Details
Q32 Bio Inc (QTTB) PE Ratio (TTM) Chart
Q32 Bio Inc (QTTB) PE Ratio (TTM) Historical Data
View and export this data going back to 2024. Start your Free Trial
Total 49
- 1
| Q32 Bio PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-04 | At Loss | 2024-04-30 | At Loss |
| 2024-06-03 | At Loss | 2024-04-29 | At Loss |
| 2024-05-31 | At Loss | 2024-04-26 | At Loss |
| 2024-05-30 | At Loss | 2024-04-25 | At Loss |
| 2024-05-29 | At Loss | 2024-04-24 | At Loss |
| 2024-05-28 | At Loss | 2024-04-23 | At Loss |
| 2024-05-24 | At Loss | 2024-04-22 | At Loss |
| 2024-05-23 | At Loss | 2024-04-19 | At Loss |
| 2024-05-22 | At Loss | 2024-04-18 | At Loss |
| 2024-05-21 | At Loss | 2024-04-17 | At Loss |
| 2024-05-20 | At Loss | 2024-04-16 | At Loss |
| 2024-05-17 | At Loss | 2024-04-15 | At Loss |
| 2024-05-16 | At Loss | 2024-04-12 | At Loss |
| 2024-05-15 | At Loss | 2024-04-11 | At Loss |
| 2024-05-14 | At Loss | 2024-04-10 | At Loss |
| 2024-05-13 | At Loss | 2024-04-09 | At Loss |
| 2024-05-10 | At Loss | 2024-04-08 | At Loss |
| 2024-05-09 | At Loss | 2024-04-05 | At Loss |
| 2024-05-08 | At Loss | 2024-04-04 | At Loss |
| 2024-05-07 | At Loss | 2024-04-03 | At Loss |
| 2024-05-06 | At Loss | 2024-04-02 | At Loss |
| 2024-05-03 | At Loss | 2024-04-01 | At Loss |
| 2024-05-02 | At Loss | 2024-03-28 | At Loss |
| 2024-05-01 | At Loss | 2024-03-27 | At Loss |
Q32 Bio Inc (QTTB) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Q32 Bio Inc
NAICS : 541714
SIC : 2833
ISIN : US7469641051
Description
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers